Dow Chemical 2012 Annual Report Download - page 53
Download and view the complete annual report
Please find page 53 of the 2012 Dow Chemical annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43 -
44 -
45 -
46 -
47 -
48 -
49 -
50 -
51 -
52 -
53 -
54 -
55 -
56 -
57 -
58 -
59 -
60 -
61 -
62 -
63 -
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
-
183
-
184
-
185
-
186
-
187
-
188
-
189
-
190
-
191
-
192
-
193
-
194
-
195
-
196
 |
 |
27
The Dow Chemical Company and Subsidiaries
PART II, Item 6. Selected Financial Data.
In millions, except as noted (Unaudited) 2012 2011 2010 2009 2008
Summary of Operations (1)
Net sales $ 56,786 $ 59,985 $ 53,674 $ 44,875 $ 57,361
Net income from continuing operations 1,100 2,784 2,321 566 626
Per share of common stock (in dollars):
Net income from continuing operations per common share - basic 0.71 2.06 1.75 0.22 0.59
Net income from continuing operations per common share - diluted 0.70 2.05 1.72 0.22 0.59
Cash dividends declared per share of common stock 1.21 0.90 0.60 0.60 1.68
Book value per share of common stock 17.73 19.28 19.23 18.42 14.62
Year-end Financial Position
Total assets $ 69,605 $ 69,224 $ 69,588 $ 66,018 $ 45,474
Long-term debt 19,919 18,310 20,605 19,152 8,042
Financial Ratios
Research and development expenses as percent of net sales 3.0% 2.7% 3.1% 3.3% 2.3%
Income from continuing operations before income taxes as percent of
net sales 2.9% 6.0% 5.2% 1.0% 2.2%
Return on stockholders’ equity 5.0% 13.1% 11.0% 2.0% 4.3%
Debt as a percent of total capitalization 48.8% 48.0% 51.3% 51.4% 45.7%
(1) Adjusted to report sale of the Calcium Chloride business in 2009 as discontinued operations.